| |
|
|
Han All Pharm. Co.,Ltd. (009420) |
|
|
STOCK |
|
|
| Address |
400-1,SANGSEO-DONG, DAEDEOK-GU, DAEJEON |
| Home Page |
www.hanall.co.kr
|
| Established |
1973.11.20 |
Tel |
042-932-5997 |
| Listed |
1989.12.18 |
IR |
02-2204-1901 |
| Common shares O/S |
37,000,000 |
President |
Kim,Seong Uk |
| Preferred shares O/S |
|
No.of Employees |
482(2008. 3) |
| Sales decreased on increased competition in the medicine market. Its profitability weakened on increased costs and widening losses. The company signed a 20 billion-won deal with Chinese Medicines for exports of antibiotic drugs. |
| The company plans to focus on developing oral protein medicine in the second half of the year. The company seeks to boost its profitability by diversifying its business lines. The company acquired a patent for DDS in March, which will help boost sales. |
|
  |
(date: 2007.12, unit : %) |
| Name |
Kim Byeongtae |
Kim Seonguk |
Bae Yeongja |
| Portion |
13.8 |
7.7 |
7.6 |
|
 |
(unit : %) |
| Sales |
Btxa |
8.0 |
Cost |
Raw Materials |
|
| Tomiporan |
7.4 |
Labors |
|
|
|
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
96.12 |
06. 5 |
06. 7 |
- |
- |
| Type |
RI |
SS |
RI |
- |
- |
| Amount |
37.29 |
500.00 |
35.00 |
- |
- |
|
|
|
|
